Evidence map›Paper›PMID 31877562›Full record

ArticlePloS one2019

The D-dimer level predicts the postoperative prognosis in patients with non-small cell lung cancer.

Yuki Shiina, Takahiro Nakajima, Takayoshi Yamamoto, Kazuhisa Tanaka, Yuichi Sakairi, Hironobu Wada, Hidemi Suzuki, Ichiro Yoshino

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yuki ShiinaDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.ORCID 0000-0003-0040-0816
Takahiro NakajimaDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.
Takayoshi YamamotoDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.
Kazuhisa TanakaDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.
Yuichi SakairiDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.
Hironobu WadaDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.
Hidemi SuzukiDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.
Ichiro YoshinoDepartment of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba Japan.
Chiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarcinoma cells often modulate coagulation and fibrinolysis among cancer patients. Plasma dimerized plasmin fragment D (D-dimer) has been reported as a prognostic marker of various types of malignancies, including non-small cell lung cancer (NSCLC). However, the associations between the plasma D-dimer level and peripheral small NSCLC remain unclear.

methodsThree hundred and sixty-two patients with NSCLC who underwent radical surgery were retrospectively reviewed. Patients who received anticoagulation therapy before surgery or who lacked preoperative D-dimer data were excluded. The other 235 patients were divided into a high D-dimer (over 1.0 μg/mL) group (HDD group, n = 47) and a normal D-dimer group (NDD group, n = 188) and investigated for their clinical characteristics, computed tomography (CT) findings, pathological findings, and clinical outcomes.

resultsThe mean D-dimer levels was 2.49±2.58 μg/ml in the HDD group and 0.42±0.23 μg/ml in the NDD group. The HDD group was characterized by a predominance of male gender, older age, pure solid appearance on chest CT, vascular invasion in pathology, and a large solid part of the tumor. The HDD group showed a worse overall survival, disease-free survival, and disease-specific survival than the NDD group (p<0.001, <0.001, <0.001, respectively). These survival features were also observed in p-Stage IA disease. There was no marked survival difference when tumors showed ground-glass opacity on CT.

conclusionIn NSCLC patients with a solid tumor appearance on CT, high D-dimer levels predict a poor survival and early recurrence.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Non-Small-Cell LungDisease-Free SurvivalFemaleFibrin Fibrinogen Degradation ProductsHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingPostoperative PeriodPrognosisRetrospective StudiesBiomarkers, TumorFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID31877562
PMCPMC6932866
OpenAlexW2996984325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.